http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013532489-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2011-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013532489-A |
| titleOfInvention | Prediction and monitoring of response to cancer treatment based on gene expression profiling |
| abstract | The present invention utilizes gene expression profiles in a method for predicting the likelihood that a patient's cancer will respond to standard therapy. Also provided are methods for identifying therapeutic agents that target cancer stem cells or epithelial cancers that have reached epithelial-mesenchymal transition using such gene expression profiles. The present invention is a method for inducing molecular formula characteristics of epithelial cancer that is not responsive to chemotherapy and anti-kinase targeted therapy. The present invention also encompasses any patient stratification scheme that utilizes the biomarkers described herein for either treatment selection and / or prognostic purposes. To do. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017515479-A |
| priorityDate | 2010-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.